Evidence map›Paper›PMID 33532091›Full record

ArticleJournal of ophthalmology2021

Toric Intraocular Lens Implantation in the Correction of Moderate-To-High Corneal Astigmatism in Cataract Patients: Clinical Efficacy and Safety.

Xiaodi Qiu, Yumeng Shi, Xiaoyan Han, Zhixiang Hua, Yi Lu, Jin Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaodi QiuEye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai 200031, China.ORCID https://orcid.org/0000-0002-5615-2949
Yumeng ShiEye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai 200031, China.ORCID https://orcid.org/0000-0001-9612-8989
Xiaoyan HanEye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai 200031, China.ORCID https://orcid.org/0000-0001-7016-8659
Zhixiang HuaEye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai 200031, China.ORCID https://orcid.org/0000-0003-3539-2393
Yi LuEye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai 200031, China.ORCID https://orcid.org/0000-0002-0245-7392
Jin YangEye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai 200031, China.ORCID https://orcid.org/0000-0002-3556-0046
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

methodsA total of 57 cataract patients (57 eyes) with regular corneal astigmatism (≥2.57 D) were enrolled in this retrospective cohort study. Phacoemulsification with toric IOL implantation was performed for all patients. The uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) were recorded before and one year after surgery, and statistical analysis of preoperative corneal astigmatism, postoperative residual astigmatism, aberrations, IOL rotation, and related factors was performed to evaluate the efficacy, safety, and stability of toric IOLs in correcting moderate-to-high corneal astigmatism.

resultsOne year after surgery, visual acuity was significantly improved compared with that before surgery (preoperative log MAR 0.87 ± 0.34 vs. postoperative log MAR 0.31 ± 0.26,

conclusionsToric IOL implantation provided optimal vision outcomes and low spectacle dependence during a one-year follow-up period. The results from our study show that toric IOL implantation is a safe and effective option for cataract patients with moderate-to-high corneal astigmatism.

Identifiers

PMID33532091
PMCPMC7840247
OpenAlexW3124198533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.